Wells Fargo
BBP icon

Wells Fargo’s Virtus Biotech ETF BBP Stock Holding History

Wells Fargo’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150
Closed -$8.71K – 7504
2023
Q4 		$8.71K Hold
150
– – ﹤0.01% 5865
2023
Q3 		$7.5K Buy
+150
New +$7.9K ﹤0.01% 5864
2021
Q2 		– Sell
-84
Closed -$4K – 6896
2021
Q1 		$4K Hold
84
– – ﹤0.01% 6530
2020
Q4 		$4K Hold
84
– – ﹤0.01% 6170
2020
Q3 		$4K Buy
+84
New +$3.91K ﹤0.01% 6038

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Wells Fargo's BBP Position: Q1 2024 in Review

Wells Fargo sold out of Virtus Biotech ETF (BBP) in Q1 2024, closing a stake of 150 shares — an estimated $8.71K sold.

Wells Fargo first reported a position in BBP in Q3 2020 and held it in 5 quarters. The position peaked at $8.71K in Q4 2023. 14 funds tracked by Wall St. Rank hold BBP as of Q1 2024.

  • Wells Fargo reported no remaining Virtus Biotech ETF position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 150 Virtus Biotech ETF shares in Q1 2024, an estimated $8.71K.
  • Wells Fargo first reported a position in Virtus Biotech ETF in Q3 2020 and held it in 5 quarters.
  • Wells Fargo's Virtus Biotech ETF position peaked at $8.71K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.